Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-89,072
Closed -$2.57M 82
2018
Q4
$2.57M Sell
89,072
-38,972
-30% -$1.68M 0.59% 45
2018
Q3
$8.39M Buy
128,044
+41,397
+48% +$2.68M 1.42% 20
2018
Q2
$5.65M Sell
86,647
-132,516
-60% -$8.31M 0.89% 31
2018
Q1
$12.1M Buy
219,163
+22,220
+11% +$1.32M 1.72% 9
2017
Q4
$13.1M Buy
196,943
+81,732
+71% +$4.82M 1.78% 6
2017
Q3
$6.79M Buy
115,211
+39,866
+53% +$1.95M 1.01% 23
2017
Q2
$3.31M Buy
75,345
+10,075
+15% +$522K 0.5% 52
2017
Q1
$3.82M Sell
65,270
-1,074
-2% -$64.4K 0.54% 47
2016
Q4
$3.89M Sell
66,344
-15,314
-19% -$873K 0.6% 41
2016
Q3
$4.28M Buy
81,658
+959
+1% +$43K 0.63% 42
2016
Q2
$3.14M Buy
+80,699
New +$2.96M 0.53% 53

Other funds holding OVV

Parkwood LLC's OVV Position: Q1 2019 in Review

Parkwood LLC sold out of Ovintiv (OVV) in Q1 2019, closing a stake of 89,072 shares — an estimated $2.57M sold.

Parkwood LLC first reported a position in OVV in Q2 2016 and held it in 11 quarters. The position peaked at $13.1M in Q4 2017. 506 funds tracked by Wall St. Rank hold OVV as of Q1 2019.

  • Parkwood LLC reported no remaining Ovintiv position as of Q1 2019 after selling out during the quarter.
  • Parkwood LLC sold 89,072 Ovintiv shares in Q1 2019, an estimated $2.57M.
  • Parkwood LLC first reported a position in Ovintiv in Q2 2016 and held it in 11 quarters.
  • Parkwood LLC's Ovintiv position peaked at $13.1M in Q4 2017.
  • 506 funds tracked by Wall St. Rank held Ovintiv as of Q1 2019.

Based on Parkwood LLC's 13F filing for Q1 2019, filed 6 May 2019.